Nyxoah results for the third quarter of 2026 are scheduled for release on November 5, the medical technology company said on October 26. Management will discuss the financial results on a conference call that day.

How to follow Nyxoah results

The call is scheduled to begin at 10:30 p.m. CET, or 4:30 p.m. ET, on November 5. Nyxoah did not disclose the quarterly financial figures in its scheduling announcement.

A live webcast will be accessible through the investor relations page of the company’s website. Nyxoah recommends that people who do not plan to ask questions listen via the webcast.

Participants who want to ask management a question must register for the call to receive dial-in details and a unique access code. The company suggests registering at least 10 minutes before the call starts. An archived webcast will be available shortly after the call ends.

About the sleep apnea company

Based in Mont-Saint-Guibert, Belgium, Nyxoah develops and commercializes treatments for obstructive sleep apnea. Its lead product, the Genio system, is a leadless, battery-free neurostimulation therapy.

The system received a European CE mark in 2019 and US Food and Drug Administration approval as a prescription-only device in August 2025. Nyxoah shares trade on Euronext Brussels and Nasdaq under the ticker NYXH.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.